-
EP0811376
European procedure
Extract from the Register of European Patents
EP About this file: EP0811376
| EP0811376 - Use of alkanoyl L-carnitines for the manufacture of a medicament for the treatment of inflammatory bowel diseases [Right-click to bookmark this link] | |||
| Former [1997/50] | Use of alkanoyl L-carnitines for the manufacture of a medicament for the treatment of chronic inflammatory bowel diseases | ||
| [2001/34] | Status | No opposition filed within time limit Status updated on 22.08.2003 Database last updated on 08.10.2024 | Most recent event Tooltip | 13.06.2008 | Change - representative | published on 16.07.2008 [2008/29] | Applicant(s) | For all designated states SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Viale Shakespeare, 47 00144 Roma / IT | [N/P] |
| Former [2002/42] | For all designated states SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. Viale Shakespeare, 47 00144 Roma / IT | ||
| Former [1997/50] | For all designated states Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. Viale Shakespeare, 47 00144 Roma / IT | Inventor(s) | 01 /
Cavazza, Claudio Piazza Campitelli 2 00186 Roma RM / IT | [1997/50] | Representative(s) | Spadaro, Marco Sigma-Tau Industrie Farmaceutiche Riunite SpA Viale Shakespeare 47 00144 Rome / IT | [N/P] |
| Former [2008/29] | Spadaro, Marco Sigma-Tau Industrie Farmaceutiche Riunite SpA Viale Shakespeare 47 00144 Rome / IT | ||
| Former [2000/01] | Spadaro, Marco (IT) Sigma-Tau Industrie Farmaceutiche Riunite SpA Patents & Trademarks Department Via Pontina, Km 30,400 I-00040 Pomezia (Roma) / IT | ||
| Former [1997/50] | Cavattoni, Fabio, et al Cavattoni & Raimondi Viale dei Parioli, 160 00197 Roma / IT | Application number, filing date | 97830270.1 | 03.06.1997 | [1997/50] | Priority number, date | IT1996RM00396 | 06.06.1996 Original published format: IT RM960396 | [1997/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP0811376 | Date: | 10.12.1997 | Language: | EN | [1997/50] | Type: | B1 Patent specification | No.: | EP0811376 | Date: | 16.10.2002 | Language: | EN | [2002/42] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 09.10.1997 | Classification | IPC: | A61K31/205, A61P29/00 | [2001/34] | CPC: |
A61K31/221 (EP,US);
A61K31/205 (KR);
A61K31/57 (EP,US);
A61P1/00 (EP);
A61P1/04 (EP);
A61P29/00 (EP);
A61K9/0031 (EP,US)
(-)
| C-Set: |
A61K31/57, A61K2300/00 (US,EP);
A61K31/57, A61K31/205 (US,EP);
A61K31/57, A61K31/22 (EP,US)
|
| Former IPC [1997/50] | A61K31/205 | Designated contracting states | AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1997/50] | Title | German: | Verwendung von Alkanoyl-L-Carnitinen zur Herstellung eines Arzneimittels zur Behandlung von entzündlichen Darmerkrankungen | [2001/34] | English: | Use of alkanoyl L-carnitines for the manufacture of a medicament for the treatment of inflammatory bowel diseases | [2001/34] | French: | Utilisation d'alcanoyl-L-carnitines pour la fabrication d'un médicament pour le traitement de maladies inflammatoires des intestins | [2001/39] |
| Former [1997/50] | Verwendung von Alkonyl-L-Carnitinen zur Herstellung eines Arzneimittels zur Behandlung von entzündlichen Darmerkrankungen | ||
| Former [1997/50] | Use of alkanoyl L-carnitines for the manufacture of a medicament for the treatment of chronic inflammatory bowel diseases | ||
| Former [1997/50] | Utilisation d'alconyl-L-carnitines pour la fabrication d'un medicament pour le traitement de maladies inflammatoires des intestins | Examination procedure | 31.03.1998 | Examination requested [1998/24] | 11.05.1998 | Despatch of a communication from the examining division (Time limit: M06) | 23.10.1998 | Reply to a communication from the examining division | 27.12.1999 | Despatch of a communication from the examining division (Time limit: M04) | 18.04.2000 | Reply to a communication from the examining division | 08.02.2001 | Despatch of a communication from the examining division (Time limit: M04) | 06.04.2001 | Reply to a communication from the examining division | 24.09.2001 | Despatch of communication of intention to grant (Approval: No) | 08.03.2002 | Despatch of a communication from the examining division (Time limit: M02) | 10.04.2002 | Despatch of communication of intention to grant (Approval: later approval) | 10.04.2002 | Reply to a communication from the examining division | 07.05.2002 | Communication of intention to grant the patent | 24.06.2002 | Fee for grant paid | 24.06.2002 | Fee for publishing/printing paid | Opposition(s) | 17.07.2003 | No opposition filed within time limit [2003/41] | Fees paid | Renewal fee | 04.05.1999 | Renewal fee patent year 03 | 06.06.2000 | Renewal fee patent year 04 | 17.05.2001 | Renewal fee patent year 05 | 16.05.2002 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]US4537772 (ALEXANDER JOSE [US], et al) [X] 9-11 * column 3, line 35 - column 4, line 68 *; | [Y]EP0559625 (SIGMA TAU IND FARMACEUTI [IT]) [Y] 1-14 * abstract *; | [X]EP0566542 (SIGMA TAU IND FARMACEUTI [IT]) [X] 9,11,12 * page 3, line 55 - page 4, line 11; claims 1-6 *; | [PX]WO9705862 (SIGMA TAU IND FARMACEUTI [IT], et al) [PX] 1-3,8 * page 2 - page 4, paragraph 2 *; | [Y] - JOHN A. JOHNSON, "L-carnitine for treatment of distal ulcerative colitis", GASTROENTEROLOGY, (1992), vol. 103, no. 5, pages 1709 - 1710, XP002041069 [Y] 1-14 * page 1710, column L, paragraphs 2-3 * | [Y] - J.SCHÖLMERICH, "Behandlung und Rezidivprophylaxe der Colitis ulcerosa", INTERNIST, (199512), vol. 36, no. 12, pages 1124 - 1132, XP002041070 [Y] 1-14 * page 1126 * * page 1128, column R; table 1 * |